Harrow, Inc. (HROW) vs Phibro Animal Health Corporation (PAHC)

Harrow, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Phibro Animal Health Corporation is the larger, with a market value of $1.4B against $1.2B — 1.1× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 14.0×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −13.5%) and the higher return on invested capital (11.7% vs −0.77%). Across the 20 metrics below, Phibro Animal Health Corporation leads on 17 and Harrow, Inc. on 3.